Press and news
July 1, 2026
Update on 2026 Outlook and Company progress
Copenhagen, Denmark, 1 July 2026 – FluoGuide A/S ("FluoGuide" or the "Company"), a clinical-stage biotech company focused on precision cancer surgery, is pleased to...
Copenhagen, Denmark, 29 June 2026 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company maximizing surgical outcomes in oncology by lighting up...
May 27, 2026
FluoGuide A/S publishes interim report for Q1 2026
Copenhagen, Denmark, 27 May 2026 – Fluoguide A/S (“FluoGuide” or the “Company”) today releases its results for the period 1 January 2026 – 31 March 2026...
May 13, 2026
Invitation to brain surgery simulation
Copenhagen, Denmark, 13 May 2026 – FluoGuide A/S ("FluoGuide" or the "Company") is inviting investors to an event on Tuesday, June 2, 2026, where participants will...
FluoGuide A/S will publish its interim report for Q1 2026 on Wednesday, 27 May 2026.
April 10, 2026
Positive interim results from an investigator-initiated study of FG001 in meningioma and low-grade glioma surgery, re-presented at SNOG
Copenhagen, Denmark, 10 April 2026 – FluoGuide A/S ("FluoGuide" or the "Company"), a clinical-stage biotech company maximizing surgical outcomes in oncology by lighting...